ASX Announcements 2010 ASX Announcements 2009 ASX Announcements 2008 ASX Announcements 2007 ASX Announcements 2006 ASX Announcements 2005 ASX Announcements 2004 ASX Announcements 2003 ASX Announcements 2002 Should you wish to view the report in your browser, you will need to have the Acrobat Reader installed. Please click on the icon (right) and follow the instructions. ASX Announcements 2007 ATL1102 Phase IIa MS Trial Update 21/12/2007   ANP Updated Company Profile 17/12/2007   Change of Constitution 29/11/2007   Results of Annual General Meeting 21/11/2007   ATL1102 Phase IIa Trial Update 21/11/2007   ATL1101 enters Pre-clinical Research in Prostate Cancer 08/11/2007   Joint Company Secretary Announcement 29/10/2007   Appendix 4C - Quarterly Cashflow Report 26/10/2007   Presentation at US Investor Conference 24/10/2007   Notice of Annual General Meeting 18/10/2007   ATL1102 MS Phase IIa Trial Update 12/09/2007   ATL1103 Project Update - Scientific Publication 31/08/2007   Letter to Shareholders 10/08/2007   Preliminary Final Report - Appendix 4E 03/08/2007   Appendix 4C Quarterly Cashflow Report 24/07/2007   ATL1102 Phase IIa Multiple Sclerosis Trial Update 22/06/2007   CEO Interview with Aegis Equities Research 08/05/2007   Company Presentation 03/05/2007   Appendix 4C - Quarterly Cashflow Report 20/04/2007   ATL1102 Phase IIa MS Trial Update 13/04/2007   Results of General Meeting 28/03/2007   Further Validation for 2nd Generation Antisense Drugs 27/03/2007   Notice of General Meeting 19/02/2007   ATL1102 - European Patent Granted 07/02/2007   Antisense/Isis Extend Development Collaboration 05/02/2007   Appendix 4D - Half Year Report 30/01/2007   Phase IIa Multiple Sclerosis Trial Update 25/01/2007   Appendix 4C - 2nd Quarter Report 24/01/2007   Option Exiry 16/01/2007